FDA requirements for importing hydrocolloid acne patches into the US
- Share
- Issue Time
- Nov 8,2026
Short answer: A hydrocolloid acne patch enters the US as a Class I medical device. The factory must be registered with FDA and the product must be listed. Your own company, as the importer, needs a US agent and must be registered as an initial importer. Three separate registrations, and shipments get held when one is missing.
Figure 1 — The three registrations, who owns each, and the order to clear them in.
The three registrations
| Who | What is required | Renewal |
|---|---|---|
| The factory | Establishment registration, receiving an FEI number | Annual |
| The product | Device listing under that registration, with classification | Annual |
| You, the importer | Initial importer registration, plus a US agent if you are offshore | Annual |
Most suppliers quote the first one and stop. The third is the one that catches first-time importers, because it is your obligation, not the factory's — and it applies before the first shipment, not after.
Does a hydrocolloid patch need 510(k) clearance?
Class I devices are generally exempt from premarket notification, and a plain hydrocolloid patch sits in that exempt group. Exemption is not the same as no requirements — the general controls still apply: establishment registration, device listing, labelling rules, and prohibitions on misbranding.
Two things move a patch out of the simple case:
- Adding an active ingredient with a therapeutic claim can shift the product toward a drug or a combination product, which changes the pathway entirely
- Claims that go beyond cosmetic spot care — treating a condition rather than concealing or absorbing — attract a different level of scrutiny
The classification follows the claim, not the material. This is why packaging copy should be settled before the artwork is printed, not after.
What customs will ask for
| Document | Purpose |
|---|---|
| Commercial invoice and packing list | Standard entry, must match the HS classification |
| FDA entry confirmation | Filed with the customs entry; the broker handles it |
| Manufacturer's FEI and device listing | Proof the factory and product are registered |
| Certificate of analysis | Batch-level specification confirmation |
| ISO 13485 certificate with scope | Supports the quality system claim if questioned |
Wording that creates problems. "FDA approved" is not a status that exists for a Class I exempt device. Using it on packaging or in listings is a misbranding risk that lands on the importer of record. "FDA registered facility" is the accurate phrase, and it should be backed by an FEI number you can verify.
The sequence that avoids holds
- Confirm the product classification and the claim before artwork
- Get the FEI and the device listing confirmation as two separate documents
- Register as initial importer and appoint a US agent — allow several weeks
- Brief your customs broker on the classification before the first shipment, not at the port
Henso Biotech manufactures in an FDA-registered facility and holds ISO 13485:2016 certification (NQA 69136, scope includes Acne Patch) and CE Class I status. We supply FEI, device listing confirmation, batch COA and stability data with commercial orders.
Tell us your destination market and importer structure, and we will confirm which documents your broker will need.